Posts Tagged ‘risk-benefit assessment’

Sunshine, Lollipops, Rainbows, and GLP-1 Meds

April 30, 2023 — Recent advances in medicines for treating obesity are stirring up quite a conversation. The enthusiasm for them is hard to miss. Subway ads, tabloid headlines, and celebrities are putting these meds front and center. From all this enthusiasm for the new GLP-1 medicines, the impression might be something like sunshine, lollipops, and rainbows. No doubt, […]